EPO production is primarily regulated by oxygen availability. When tissues experience hypoxia (low oxygen levels), hypoxia-inducible factors (HIF) stabilize and activate the transcription of the EPO gene. This leads to increased production of EPO, which in turn stimulates the bone marrow to produce more RBCs. Once oxygen levels are restored, the production of EPO diminishes.
